Evolent Health Inc (STU:9EH)
€ 13 -1.5 (-10.34%) Market Cap: 1.62 Bil Enterprise Value: 2.13 Bil PE Ratio: 0 PB Ratio: 1.68 GF Score: 72/100

Evolent Health Inc at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 07:35PM GMT
Release Date Price: €28.2 (-2.76%)
Steven James Valiquette;John Paul Johnson<
Barclays Bank PLC, Research Division - Research Analyst

Next session here. I'm Steven Valiquette, the healthcare services analyst here at Barclays. This session will be with Evolent Health. With us from the company, to my right is John Johnson, the company's CFO.

This will be a fireside chat. I think with that, I guess we'll just -- we'll dive right in. And this is a company that I don't -- have ever officially covered. So not 100% plugged in out of some of the nuances, we'll dive into some of the things that are key within the company. I think first, there's been a lot of evolution within the company and also just within value-based care overall, obviously, within the industry and even for you guys as well. But -- so just start high level for others that might be less familiar with the company, just do kind of a quick walk-through of how that evolution has occurred over the past 5 or 10 years or so from more of a technology or solutions type offering to more of a greater services offering. Then we'll just kind of expand from there.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot